1300 GMT - Roche's $50 billion U.S. investment signals that president Trump's pressure tactics amid tariffs prospects are proving effective, AlphaValue analysts say in a note. The Swiss pharma giant's five-year $50 billion pledge in U.S. manufacturing and R&D joins a growing trend of companies increasing investment in the country, they say. Roche shares fall 2% to 250.60 Swiss Francs. (helena.smolak@wsj.com)
(END) Dow Jones Newswires
April 22, 2025 09:03 ET (13:03 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。